ITGA9 and neoplasm: A multiple correspondence analysis was carried out in order to suggest clinical and genetic associations between the methylation status of ITGA1, ITGA4, ITGA9, NID1, and NID2 and clinical/morphological characteristics of the tumors, including the disease stage, tumor grade, tumor type, as well as estrogen receptor, progesterone receptor, and HER2 expression assessed by immunohistochemistry (IHC).